Eversight announced it has awarded grants through the Eversight Center for Vision and Eye Banking Research to support essential optical research. Recipients from several institutions were selected by an independent review panel comprised of foremost academics, ophthalmologists and health services researchers. Proposals selected for funding align with Eversight’s mission to restore sight and prevent blindness through meaningful scientific inquisition.
2019 grant recipients and their proposals include:
- Reza Dana, M.D., Professor of Ophthalmology at Harvard Medical School and Director of Cornea and Refractive Surgery at Massachusetts Eye and Ear, is investigating aqueous humor cytokines and chemokines in DMEK vs. DSEK graft failure. Dana’s findings may broaden the field’s understanding of the role of immune system factors responsible for endothelial keratoplasty graft failure, which could inform future efforts to improve procedural success rates.
- Abigail Fahim, M.D., Ph.D., Clinical Assistant Professor of Ophthalmology and Visual Sciences at the Kellogg Eye Center at the University of Michigan Medical School, is investigating choroideremia pathophysiology using iPSC-derived retinal pigment epithelium. Fahim’s findings may determine potential new therapeutic agents for chorioretinal degenerations, including age-related macular degeneration, expanding treatment options for patients.
- Victor Guaiquil, Ph.D., Assistant Research Professor of Ophthalmology at the University of Illinois College of Medicine, is investigating the role of axon guidance proteins in the injured cornea. Guaiquil’s gene and protein expression analysis may explain the molecular mechanisms of corneal neuropathies and further inform the prevention and treatment of unexplainable eye pain.
- Pedram Hamrah, M.D., Professor of Ophthalmology at Tufts University School of Medicine, is investigating the efficacy of plasmacytoid dendritic cell local adoptive transfer on host immune response to corneal graft and graft survival. Hamrah’s findings may yield fundamental information about the significance of plasmacytoid dendritic cells in corneal transplantation and could lead to novel therapeutic approaches for other corneal inflammatory conditions, as well as other solid-tissue transplants.
- Kai Kang, M.D., Assistant Professor of Ophthalmology at the University of Illinois College of Medicine, is investigating the effect of microbiome on corneal epithelial healing and corneal regenerative potential. Kang’s findings may shed light on the exact mechanism of the corneal-microbiome interaction and initiate further inquiry into the feasibility of corneal regeneration.
- Susmit Suvas, Ph.D., Associate Professor of Ophthalmology, Visual and Anatomical Sciences at Wayne State University School of Medicine, is investigating novel therapeutic approaches to alleviate the severity of necrotizing herpes stromal keratitis. Suvas’ findings may create a promising therapy to effectively reduce stromal inflammation for patients and improve healing of corneal epithelium in those who are developing herpes stromal keratitis.
Eversight has a robust research and development history and has awarded more than $4 million in grant funding to fuel scientific exploration in the field of ophthalmology. Many of these projects have stimulated larger-scale studies and won further financial support from the National Institutes of Health. Applications for the Eversight Eye & Vision Research Grant Program will reopen in early 2020.
Full news release: https://www.eversightvision.org/eversight-awards-2019-eye-vision-research-grants/